ADA Scientific Sessions 2026 Abstract

HM500197, a De Novo–Designed Long-Acting Peptide Myostatin Inhibitor, Improves Skeletal Muscle Mass and Body Composition in Diet-Induced Obese Mice

By Jaehyuk Choi, Jinyoung Kim, Jae Young Kim, In Young Choi

Experiments in animalsInterventions

The paper

Jaehyuk Choi, Jinyoung Kim, Jae Young Kim, In Young Choi

Hwaseong-si

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 3073-LB

doi.org/10.2337/db26-3073-lb

JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Diabetes, Obesity & Metabolism4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk